Relating Chemical Structure to Cellular Response: An Integrative Analysis of Gene Expression, Bioactivity, and Structural Data Across 11,000 Compounds

CPT: Pharmacometrics and Systems Pharmacology

Volumn 4, Issue 10, 2015, Pages 576-584

  Chen, B ^a   Greenside, P ^b   Paik, H ^a   Sirota, M ^a   Hadley, D ^a   Butte, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IDARUBICIN; MEDROXYPROGESTERONE; NORETHISTERONE; PANCURONIUM; TESTOSTERONE; VECURONIUM; VINCRISTINE; VINDESINE;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FINGER DERMATOGLYPHICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; PRIORITY JOURNAL; TREATMENT DURATION; WORKFLOW;

EID: 84945272320     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1002/psp4.12009     Document Type: Article

References (27)

1. Martin, Y.C., Kofron, J.L., &, Traphagen, L.M., Do structurally similar molecules have similar biological activity? J. Med. Chem. 45, 4350-4358 (2002).
2. Stumpfe, D., &, Bajorath, J., Exploring activity cliffs in medicinal chemistry. J. Med. Chem. 55, 2932-2942 (2012).
3. Bender, A., &, Glen, R.C., Molecular similarity: a key technique in molecular informatics. Organ. Biomol. Chem. 2, 3204-3218 (2004).
4. Nissen, S.E., &, Wolski, K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356, 2457-2471 (2007).
5. Menon, K.V.N., Angulo, P., &, Lindor, K.D., Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus. Am. J. Gastroenterol. 96, 1631-1634 (2001).
6. Fliri, A.F., Loging, W.T., Thadeio, P.F., &, Volkmann, R.A., Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. J. Med. Chem. 48, 6918-6925 (2005).
7. Fliri, A.F., Loging, W.T., Thadeio, P.F., &, Volkmann, R.A., Biological spectra analysis: linking biological activity profiles to molecular structure. Proc. Natl. Acad. Sci. U.S.A. 102, 261-266 (2005).
8. Petrone, P.M., et al,. Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem. Biol. 7, 1399-1409 (2012).
9. Campillos, M., Kuhn, M., Gavin, A.C., Jensen, L.J., &, Bork, P., Drug target identification using side-effect similarity. Science 321, 263-236 (2008).
10. Gottlieb, A., Stein, G.Y., Ruppin, E., &, Sharan, R., PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol. 7, 496 (2011).
11. Covell, D.G., Wallqvist, A., Huang, R., Thanki, N., Rabow, A.A., &, Lu, X.J., Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 59, 403-433 (2005).
12. Fernald, G.H., &, Altman, R.B., Using molecular features of xenobiotics to predict hepatic gene expression response. J. Chem. Inf. Model. 53, 2765-2773 (2013).
13. Fliri, A.F., Loging, W.T., Thadeio, P.F., &, Volkmann, R.A., Analysis of drug-induced effect patterns to link structure and side effects of medicines. Nat. Chem. Biol. 1, 389-397 (2005).
14. Chen, B., McConnell, K.J., Wale, N., Wild, D.J., &, Gifford, E.M., Comparing bioassay response and similarity ensemble approaches to probing protein pharmacology. Bioinformatics 27, 3044-3049 (2011).
15. Iorio, F., Tagliaferri, R., &, di Bernardo, D., Identifying network of drug mode of action by gene expression profiling. J. Comput. Biol. 16, 241-251 (2009).
16. Qu, X.A., &, Rajpal, D.K., Applications of Connectivity Map in drug discovery and development. Drug Discov. Today 17, 1289-1298 (2012).
17. Sirota, M., et al,. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3, 96ra77 (2011).
18. Cheng, C., et al,. Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Res. 22, 1658-1667 (2012).
19. Kininis, M., &, Kraus, W.L., A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl. Recept. Signal. 6, e005 (2008).
20. Blower, P.E., et al,. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenom. J. 2, 259-271 (2002).
21. Liu, C., Su, J., Yang, F., Wei, K., Ma, J., &, Zhou, X., Compound signature detection on LINCS L1000 big data. Mol. Biosyst. 11, 714-722 (2015).
22. Vidovic, D., Koleti, A., &, Schurer, S.C., Large-scale integration of small molecule-induced genome-wide transcriptional responses, Kinome-wide binding affinities and cell-growth inhibition profiles reveal global trends characterizing systems-level drug action. Front. Genet. 5, 342 (2014).
23. Olson, D.E., et al,. An unbiased approach to identify endogenous substrates of "histone" deacetylase 8. ACS Chem. Biol. 9, 2210-2216 (2014).
24. Ma'ayan, A., Rouillard, A.D., Clark, N.R., Wang, Z., Duan, Q., &, Kou, Y., Lean Big Data integration in systems biology and systems pharmacology. Trends Pharmacol. Sci. 35, 450-460 (2014).
25. Wang, Y., Xiao, J., Suzek, T.O., Zhang, J., Wang, J., &, Bryant, S.H., PubChem: a public information system for analyzing bioactivities of small molecules. Nucl. Acids Res. 37, W623-633 (2009).
26. Rogers, D., &, Hahn, M., Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742-754 (2010).
27. Huang da, W., Sherman, B.T., &, Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).